A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

UCL Technology Fund: an unparalleled approach to commercialisation
Editor Thierry Heles sits down with David Grimm, manager of the UCL Technology Fund, to find out what makes the fund unique among its UK and international peers.
CSU discloses 2018 tech transfer results
CSU Ventures added five spinouts and 36 licensing agreements to its portfolio during the 2018 fiscal year, taking its total to 45 and 315 respectively.
Yale decrypts investment for $400m fund
Yale University’s endowment will reportedly back a $400m cryptocurrency-focused fund called Paradigm together with investors including Sequoia Capital.
OxStem derives subsidiaries
Oxford regenerative medicine spinout OxStem, which raised $24.4m in 2016, has launched two subsidiaries to focus on therapies for diabetes, chronic inflammation and wound healing.
Adranos takes off with $800,000
The 2016 Purdue spinout has been backed by angel investor Archibald Cox and the Ustar Tap accelerator as it seeks US defence agency-adoption for its missile propellant.
OmniSci maps out $55m series C
Johns Hopkins oncology diagnostics spinout PGDx had previously raised approximately $99m.
Orchard to orchestrate $173m IPO
The UCL Technology Fund is in line for an exit from gene therapy developer Orchard Therapeutics, which has raised more than $290m in equity funding.
Theodorus unveils $23m fund
Université libre de Bruxelles has added a fourth Theodorus fund to its arsenal with an initial close of $23m and a target of up to $33.5m.
Caristo detects $2.6m pulse
The newly-founded Oxford cardiovascular imaging spinout raised seed funding from backers including Oxford Sciences Innovation to pursue further product development.
Nanosive heats up Truffle Capital investment
Sun protection product developer Nanosive has been launched by Truffle Capital with a licence from Yale University.
PGDx intersects with Innovatus in $42m deal
Johns Hopkins oncology diagnostics spinout PGDx had previously raised approximately $99m.
Chrysalix brings Delft to RoboValley for first close
The Delft-affiliated fund has reached its first close on its way to a $120m target, having secured capital from a range of limited partners.
Yissum fabricates $6m nanotech fund
HUJ’s tech transfer arm still hopes to raise a further $3m for the fund to close it at $9m and has already invested in three technologies.
Michigan doubles spinout total in 2017-18
The university’s Office of Technology Transfer launched 21 spinouts while achieving a 10% rise in inventions disclosed and a record number of licences and options agreed.
Glympse Bio engineers $22m series A
Glympse Bio, a medical diagnostic sensor spinout from MIT, has secured $22m in a series A round ahead of clinical trials targeting fatty liver disease and cancer.
Gotham goes to $54m in series A
Cornell spinout Gotham Therapeutics has come out of stealth with a series A round co-led by SR One, Versant Ventures and Forbion.
Soffer surges on from Technion
Ben Soffer will stand down as managing director of Technion Technology Transfer after 13 years in charge.
Covatic covets $1.1m investment
Oxford spinout Covatic has now raised $2.1m in funding for a software platform that enables media broadcasters to tailor mobile content and marketing to the habits of specific users.
Rgenix generates $40m series C
The Rockefeller spinout will use the series C proceeds to advance two cancer drug candidates through early-stage clinical trials.
Canada puts $25m into Toronto’s Creative Destruction
Canada’s Strategic Innovation Fund will provide $19.2m for accelerator Creative Destruction Lab over four years with the aim of supporting more than 1,300 science-focused companies.
Mission Secure shields $8m for series A
University of Virginia Seed Fund returned to back industrial cybersecurity spinout Mission Secure in a round co-led by Chevron Technology Ventures and Energy Innovation Capital.